Skip to main content

Table 3 Sensitivity analysis

From: Update of the ULtra-early TRranexamic Acid after Subarachnoid Hemorrhage (ULTRA) trial: statistical analysis plan

 

ITT

TXA group

Standard care group

OR (95% CI)

aOR (95% CI)

Excellent outcome (mRS 0–2)

NN (X %)

NN (X %)

X.XX (X.XX–X.XX)

X.XX (X.XX–X.XX)

Ordinal shift mRS)

NN (X %)

NN (X %)

X.XX (X.XX–X.XX)

X.XX (X.XX–X.XX)

 mRS0

 mRS1

 mRS2

 mRS3

 mRS4

 mRS5

 mRS6

  1. Data are n (%), mean (SD), or median (IQR)
  2. aOR adjusted odds ratio, CI confidence interval, ITT intention to treat, mRS modified Rankin Scale, OR odds ratio, TXA tranexamic acid
Back to article page

Trials

ISSN: 1745-6215